东方生物

- 688298

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016 
东方生物(688298) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入18,292.2582,015.7365,217.1950,154.3937,604.53
营业收入18,292.2582,015.7365,217.1950,154.3937,604.53
二、营业总成本28,654.88100,229.9471,871.9845,756.6642,427.46
营业成本12,374.5946,740.2740,998.5632,366.3225,295.96
营业税金及附加117.431,506.85564.44355.42292.16
销售费用3,473.3216,219.0811,707.787,626.424,021.26
管理费用9,002.4537,235.7324,998.5615,773.517,721.29
财务费用-3,509.36-27,558.14-25,210.91-22,738.98-93.68
研发费用7,196.4526,086.1518,813.5512,373.965,190.48
资产减值损失----------
公允价值变动收益2,814.60-898.98-92.95-92.95-92.95
投资收益1,527.834,201.433,038.242,140.181,062.18
其中:对联营企业和合营企业的投资收益-86.11-149.85-131.39-45.92-18.81
汇兑收益----------
三、营业利润-6,745.47-38,383.47-4,443.796,073.12-144.57
加:营业外收入1.62421.11425.94421.1866.50
减:营业外支出67.872,460.32606.15572.633,687.43
其中:非流动资产处置损失----------
四、利润总额-6,811.72-40,422.67-4,624.005,921.67-3,765.50
减:所得税费用183.801,404.212,102.632,127.03875.78
五、净利润-6,995.53-41,826.88-6,726.643,794.63-4,641.29
归属于母公司所有者的净利润-6,735.35-39,758.36-7,238.403,480.76-5,033.01
少数股东损益-260.18-2,068.52511.76313.87391.72
六、每股收益
基本每股收益(元/股)-0.3300-1.9700-0.36000.1700-0.3000
稀释每股收益(元/股)-0.3300-1.9700-0.36000.1700-0.3000
七、其他综合收益-835.291,410.702,487.802,891.97-1,326.08
八、综合收益总额-7,830.82-40,416.18-4,238.836,686.60-5,967.37
归属于母公司所有者的综合收益总额-7,570.64-38,347.66-4,750.606,372.73-6,359.09
归属于少数股东的综合收益总额-260.18-2,068.52511.76313.87391.72
下载全部历史数据到excel中 返回页顶